lamotrigine
NDC 31722-245, lamotrigine extended-release, tablet, film coated, extended release, from Camber Pharmaceuticals Inc.
- Product NDC
- 31722-245
- Status
- Listed
- Labeler
- Camber Pharmaceuticals Inc
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213949
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-245-30 | 31722024530 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (31722-245-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e45bd69f-3580-ff15-e053-2a95a90a4615NADAC price for package 31722024530
GET /v1/drugs/nadac/31722024530
Use it
Look up 31722-245 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-245 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-245. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.